The Washington Post @washingtonpost
The good news comes with a caveat: The vaccine may not begin to have a large impact on the pandemic until late summer or fall. In the U.S., Novavax still needs to file for emergency authorization. https://t.co/hDl5EnvHWL — PolitiTweet.org
